You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

Actavis Elizabeth Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ACTAVIS ELIZABETH, and what generic and branded alternatives to ACTAVIS ELIZABETH drugs are available?

ACTAVIS ELIZABETH has one hundred and seventeen approved drugs.

There are five tentative approvals on ACTAVIS ELIZABETH drugs.

Summary for Actavis Elizabeth

US Patents:	0
Tradenames:	77
Ingredients:	77
NDAs:	117
Patent Litigation for Actavis Elizabeth:	See patent lawsuits for Actavis Elizabeth
PTAB Cases with Actavis Elizabeth as petitioner:	See PTAB cases with Actavis Elizabeth as petitioner

Drugs and US Patents for Actavis Elizabeth

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Actavis Elizabeth	MIRTAZAPINE	mirtazapine	TABLET, ORALLY DISINTEGRATING;ORAL	076689-002	Aug 31, 2005		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Elizabeth	QUINAPRIL HYDROCHLORIDE	quinapril hydrochloride	TABLET;ORAL	076459-001	Dec 22, 2004		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Elizabeth	PREGABALIN	pregabalin	CAPSULE;ORAL	091025-007	Jul 9, 2020	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Elizabeth	RAMIPRIL	ramipril	CAPSULE;ORAL	077513-002	Jun 18, 2008		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Elizabeth	TRAMADOL HYDROCHLORIDE	tramadol hydrochloride	TABLET;ORAL	075960-001	Jun 19, 2002		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
Actavis Elizabeth	RANOLAZINE	ranolazine	TABLET, EXTENDED RELEASE;ORAL	208862-001	May 28, 2019	AB	RX	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.